Mediational models of maternal stress in neonatal intensive care units.

Background: Maternal stress in neonatal intensive care units (NICUs) is well acknowledged. However, there is currently no well-defined support at how to best assist mothers during their infants' hospitalization. Not only must they confront at the same time their infant's fragility, but also their own personal trials.

The Impact of Asymptomatic Congenital Cytomegalovirus on Adult Quality of Life.

Objective: Children born with asymptomatic congenital cytomegalovirus infection (AcCMV) have increased risk for hearing loss, which may affect their quality of life into adulthood. We aim to determine quality of life outcomes among adults who were identified at birth with AcCMV compared with controls, using the cohort of the Houston Congenital CMV Longitudinal Study.

Methods: Quality of life was determined using the self-reported Quality of Life Inventory (QOLI).

Intelligence and Academic Achievement With Asymptomatic Congenital Cytomegalovirus Infection.

Objectives: To examine intelligence, language, and academic achievement through 18 years of age among children with congenital cytomegalovirus infection identified through hospital-based newborn screening who were asymptomatic at birth compared with uninfected infants.

Methods: We used growth curve modeling to analyze trends in IQ (full-scale, verbal, and nonverbal intelligence), receptive and expressive vocabulary, and academic achievement in math and reading. Separate models were fit for each outcome, modeling the change in overall scores with increasing age for patients with normal hearing ( = 78) or with sensorineural hearing loss (SNHL) diagnosed by 2 years of age ( = 11) and controls ( = 40).

Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants.

Objective: We previously reported better psychomotor development at 30 months of age in infants whose mothers received a docosahexaenoic acid (DHA) (22:6n-3) supplement for the first 4 months of lactation. We now assess neuropsychological and visual function of the same children at 5 years of age.

Study Design: Breastfeeding women were assigned to receive identical capsules containing either a high-DHA algal oil (∼200 mg/d of DHA) or a vegetable oil (containing no DHA) from delivery until 4 months postpartum.

Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants.

Background: Normal brain and visual development is thought to require exogenous docosahexaenoic acid (DHA; 22:6n-3) intake, but the amount needed is debatable. Because the supplementation of breastfeeding mothers with DHA increases the DHA content of their infants' plasma lipids, we hypothesized that it might also improve brain or visual function in the infants.

Objective: The objective was to determine the effect of DHA supplementation of breastfeeding mothers on neurodevelopmental status and visual function in the recipient infant.